483 related articles for article (PubMed ID: 16703453)
1. Female predominance in meningiomas can not be explained by differences in progesterone, estrogen, or androgen receptor expression.
Korhonen K; Salminen T; Raitanen J; Auvinen A; Isola J; Haapasalo H
J Neurooncol; 2006 Oct; 80(1):1-7. PubMed ID: 16703453
[TBL] [Abstract][Full Text] [Related]
2. Progesterone-receptor index in meningiomas: correlation with clinico-pathological parameters and review of the literature.
Wolfsberger S; Doostkam S; Boecher-Schwarz HG; Roessler K; van Trotsenburg M; Hainfellner JA; Knosp E
Neurosurg Rev; 2004 Oct; 27(4):238-45. PubMed ID: 15168138
[TBL] [Abstract][Full Text] [Related]
3. Clinical features and immunohistochemical expression levels of androgen, estrogen, progesterone and Ki-67 receptors in relationship with gross-total resected meningiomas relapse.
Tao Y; Liang G; Li Z; Wang Y; Wu A; Wang H; Lu Y; Liu Z; Hu G
Br J Neurosurg; 2012 Oct; 26(5):700-4. PubMed ID: 22616825
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical expression of aromatase and estrogen, androgen and progesterone receptors in normal and neoplastic human meningeal cells.
Leães CG; Meurer RT; Coutinho LB; Ferreira NP; Pereira-Lima JF; da Costa Oliveira M
Neuropathology; 2010 Feb; 30(1):44-9. PubMed ID: 19703265
[TBL] [Abstract][Full Text] [Related]
5. Status of Ki-67, estrogen and progesterone receptors in various subtypes of intracranial meningiomas.
Fakhrjou A; Meshkini A; Shadrvan S
Pak J Biol Sci; 2012 Jun; 15(11):530-5. PubMed ID: 24191627
[TBL] [Abstract][Full Text] [Related]
6. Gonadotropin-releasing hormone (GnRH) and its receptor in human meningiomas.
Hirota Y; Tachibana O; Uchiyama N; Hayashi Y; Nakada M; Kita D; Watanabe T; Higashi R; Hamada J; Hayashi Y
Clin Neurol Neurosurg; 2009 Feb; 111(2):127-33. PubMed ID: 18980792
[TBL] [Abstract][Full Text] [Related]
7. Proliferation and progesterone receptor status in benign meningiomas are not age dependent.
Roser F; Nakamura M; Ritz R; Bellinzona M; Dietz K; Samii M; Tatagiba MS
Cancer; 2005 Aug; 104(3):598-601. PubMed ID: 15952201
[TBL] [Abstract][Full Text] [Related]
8. Detection of progesterone receptor and the correlation with Ki-67 labeling index in meningiomas.
Mukherjee S; Ghosh SN; Chatterjee U; Chatterjee S
Neurol India; 2011; 59(6):817-22. PubMed ID: 22234191
[TBL] [Abstract][Full Text] [Related]
9. Immunoreactive estrogen receptor protein in meningiomas: comparison with the androgen receptor and progesterone receptor binding activity.
Lesch KP; Engl HG; Schott W; Gross S
Zentralbl Neurochir; 1987; 48(2):124-34. PubMed ID: 3314266
[TBL] [Abstract][Full Text] [Related]
10. Recurrence of benign meningiomas: predictive value of proliferative index, BCL2, p53, hormonal receptors and HER2 expression.
Abdelzaher E; El-Gendi SM; Yehya A; Gowil AG
Br J Neurosurg; 2011 Dec; 25(6):707-13. PubMed ID: 20979437
[TBL] [Abstract][Full Text] [Related]
11. Expression of androgen and progesterone receptors in primary human meningiomas.
Maxwell M; Galanopoulos T; Neville-Golden J; Antoniades HN
J Neurosurg; 1993 Mar; 78(3):456-62. PubMed ID: 8433149
[TBL] [Abstract][Full Text] [Related]
12. Steroid hormone receptors in meningiomas of Chinese patients.
Lee LS; Chi CW; Chang TJ; Chou MD; Liu HC; Liu TY
Neurosurgery; 1989 Oct; 25(4):541-5. PubMed ID: 2797392
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical expression of apoptosis regulating proteins and sex hormone receptors in meningiomas.
Takei H; Buckleair LW; Powell SZ
Neuropathology; 2008 Feb; 28(1):62-8. PubMed ID: 18021195
[TBL] [Abstract][Full Text] [Related]
14. Expression of progestrone receptor and proliferative marker ki 67 in various grades of meningioma.
Shayanfar N; Mashayekh M; Mohammadpour M
Acta Med Iran; 2010; 48(3):142-7. PubMed ID: 21137648
[TBL] [Abstract][Full Text] [Related]
15. Estrogen receptor immunoreactivity in meningiomas. Comparison with the binding activity of estrogen, progesterone, and androgen receptors.
Lesch KP; Gross S
J Neurosurg; 1987 Aug; 67(2):237-43. PubMed ID: 3298569
[TBL] [Abstract][Full Text] [Related]
16. Sex steroid receptors in diverse human tumors.
Kobayashi S; Mizuno T; Tobioka N; Ichimura H; Samoto T; Tanaka H; Masaoka A; Wakabayashi S; Umemura S; Fukuoka H; Nagai H
Gan; 1982 Jun; 73(3):439-45. PubMed ID: 6290306
[TBL] [Abstract][Full Text] [Related]
17. Estrogen and progesterone receptor in meningiomas: An immunohistochemical analysis.
Telugu RB; Chowhan AK; Rukmangadha N; Patnayak R; Phaneendra BV; Mowliswara Prasad BC; Reddy MK
J Cancer Res Ther; 2020; 16(6):1482-1487. PubMed ID: 33342817
[TBL] [Abstract][Full Text] [Related]
18. New Insights into Expression of Hormonal Receptors by Meningiomas.
Portet S; Banor T; Bousquet J; Simonneau A; Flores M; Ingrand P; Milin S; Karayan-Tapon L; Bataille B
World Neurosurg; 2020 Aug; 140():e87-e96. PubMed ID: 32371078
[TBL] [Abstract][Full Text] [Related]
19. Recurrences of meningiomas: predictive value of pathological features and hormonal and growth factors.
Maiuri F; De Caro MB; Esposito F; Cappabianca P; Strazzullo V; Pettinato G; de Divitiis E
J Neurooncol; 2007 Mar; 82(1):63-8. PubMed ID: 17225937
[TBL] [Abstract][Full Text] [Related]
20. Is progesteron receptor status really a prognostic factor for intracranial meningiomas?
Iplikcioglu AC; Hatiboglu MA; Ozek E; Ozcan D
Clin Neurol Neurosurg; 2014 Sep; 124():119-22. PubMed ID: 25036873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
